http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_90f7c72d3c0848f1ad50a9ded0fb7979
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Nelson |
| name | Mark T. Nelson Mark T Nelson |
| given-name | Mark T Mark T. |
| organization-name | Department of Pharmacology, University of Vermont College of Medicine, Burlington, Vermont; and; Institute of Cardiovascular Sciences, University of Manchester, Manchester, United Kingdom Department of Pharmacology, University of Vermont, Burlington, VT 05405;; Institute of Cardiovascular Sciences, University of Manchester, Manchester M13 9NT, United Kingdom Department of Pharmacology, University of Vermont College of Medicine, Burlington, Vermont;; Cardiovascular Medicine, Faculty of Medical and Human Sciences, University of Manchester, Manchester, United Kingdom Department of Pharmacology, Larner College of Medicine, University of Vermont, Burlington, VT 05405;; Vermont Center for Cardiovascular and Brain Health, University of Vermont, Burlington, VT 05405;; Division of Cardiovascular Sciences, University of Manchester, Manchester M13 9PL, United Kingdom Department of Pharmacology, Larner College of Medicine, University of Vermont, Burlington, Vermont Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PL, United Kingdom; Geoffrey Jefferson Brain Research Centre, The Manchester Academic Health Science Centre, Northern Care Alliance National Health Service Foundation Trust, University of Manchester, Manchester M13 9PL, United Kingdom; Department of Pharmacology, Larner College of Medicine, University of Vermont, Burlington, VT 05405 Department of Pharmacology College of Medicine The University of Vermont Burlington VT Department of Pharmacology, University of Vermont College of Medicine, Burlington, Vermont; Department of Pharmacology, College of Medicine, University of Vermont, Burlington, VT 05405;; Division of Cardiovascular Sciences, University of Manchester, Manchester M13 9PL, United Kingdom; Department of Pharmacology, University of Vermont, Burlington, VT, USA; Division of Cardiovascular Sciences, University of Manchester, Manchester, UK Department of Pharmacology, University of Vermont, Burlington, VT 05405 1; Division of Cardiovascular and Endocrine Sciences, University of Manchester, Manchester M13 9PL, England, UK 2 Department of Pharmacology, University of Vermont, Burlington, VT 05405 3 Department of Pharmacology and Vermont Center for Vascular Research, The University of Vermont, Medical Research Facility, Colchester, VT 05446 From the Departments of Pharmacology (G.C.W., D.J.N., C.M.S., G.P., A.D.B., P.L.P., M.T.N.) and Surgery (G.C.W., D.J.N., P.L.P., B.I.T.), University of Vermont College of Medicine, Burlington. Department of Pharmacology, The University of Vermont, College of Medicine, Burlington, Vermont 05405 Department of Pharmacology, University of Vermont, Burlington, Vermont 05405 Department of Pharmacology, College of Medicine University of Vermont Burlington VT; Institute of Cardiovascular Sciences University of Manchester Manchester United Kingdom Department of Pharnacology, University of Vernont College of Medicine, Burlington, VT 05405. From the *Department of Pharmacology and ‡Department of Molecular Physiology and Biophysics, The University of Vermont, Burlington, Vermont 05405 Pharmacology, University of Vermont, Burlington, VT 05405; Department of Pharmacology, University of Vermont, Burlington, Vermont.; Department of Surgery, University of Vermont, Burlington, Vermont.; Institute of Cardiovascular Sciences, University of Manchester, Manchester, United Kingdom. From the Department of Molecular and Cellular Physiology (J.J.Z., T.L.S.), Beckman Center, Stanford University Medical Center, Stanford, Calif; and Department of Pharmacology (D.M.E., G.C.W., M.T.N.), University of Vermont College of Medicine (Burlington). Department of Pharmacology, University of Vermont College of Medicine, Burlington, Vermont 05405-0068; and From the Department of Pharmacology, College of Medicine, University of Vermont, Burlington. From the Department of Pharmacology, University of Vermont College of Medicine, Burlington. Department of Pharmacology, University of Vermont, Burlington, Vermont, USA Department of Pharmacology, College of Medicine, University of Vermont, Burlington, United States; Institute of Cardiovascular Sciences, University of Manchester, Manchester, United Kingdom Department of Pharmacology, University of Vermont, Colchester, Vermont 05446; and Division of Cardiovascular Sciences; Faculty of Biology, Medicine and Health; University of Manchester; Manchester UK; Department of Pharmacology; University of Vermont; Burlington Vermont Department of Pharmacology, College of Medicine, University of Vermont, Burlington, Vermont Division of Cardiovascular Sciences Faculty of Biology, Medicine and Health University of Manchester Health Innovation Manchester Network Manchester United Kingdom; Department of Pharmacology University of Vermont Burlington Vermont Department of Pharmacology University of Vermont College of Medicine Burlington VT 05405 USA; Institute of Cardiovascular Sciences University of Manchester Manchester UK Department of Pharmacology University of Vermont College of Medicine Burlington Vermont From the Department of Pharmacology (M.S.T., A.D.B., T.P.G., D.M.E., J.E.B., M.T.N.), University of Vermont, Burlington, Vt, and Oregon Health Sciences University (C.T.B., J.P.A.), Portland, Ore. Department of Pharmacology, Larner College of Medicine, University of Vermont, Burlington, VT 05405; Division of Cardiovascular Sciences, University of Manchester, Manchester M13 9PL, UK Department of Pharmacology, University of Vermont, Burlington, VT 05404;; Division of Cardiovascular Sciences, University of Manchester, M13 9PL Manchester, United Kingdom Department of Pharmacology, University of Vermont College of Medicine, Burlington, Vermont Department of Pharmacology, College of Medicine, University of Vermont, Burlington (N.R.K., F.D., M.T.N., A.J.).; Division of Cardiovascular Sciences, University of Manchester, United Kingdom (M.T.N.). Department of Pharmacology and; Department of Cardiovascular Medicine, Faculty of Medical and Human Sciences, University of Manchester, Manchester, United Kingdom Department of Pharmacology, University of Vermont College of Medicine, Burlington, Vermont, USA Department of Pharmacology, University of Vermont, Burlington, VT, USA Department of Pharmacology, University of Vermont College of Medicine, Burlington, VT 05405 Department of Pharmacology, University of Vermont , 05405 Burlington, VT , USA; Division of Cardiovascular Sciences, University of Manchester , M139WU Manchester , UK the Department of Pharmacology, The University of Vermont, UVM Medical Research Facility, Colchester. From the Department of Pharmacology, University of Vermont College of Medicine, Burlington, Vt. Departments of aPharmacology and; Institute of Cardiovascular Sciences, University of Manchester, Manchester M13 9PL, United Kingdom Pharmacology, and Department of Pharmacology, University of Vermont, Burlington, VT 05405 1; Institute of Cardiovascular Sciences, University of Manchester, Manchester M13 9NT, England, UK 2 Department of Pharmacology, University of Vermont, Burlington, VT 05405, USA.; Institute of Cardiovascular Sciences, University of Manchester, Manchester M13 9NT, UK. Department of Pharmacology, University of Vermont College of Medicine, Burlington, Vermont 05405 Department of Pharmacology, College of Medicine, University of Vermont, Burlington, Vermont, USA; Institute of Cardiovascular Sciences, University of Manchester, Manchester, UK Department of Pharmacology and Department of Pharmacology, University of Vermont College of Medicine, Burlington, VT 05405; and; Institute of Cardiovascular Sciences, University of Manchester, Manchester M13 9NT, United Kingdom Pharmacology, College of Medicine, University of Vermont, Burlington, Vermont 05405 Department of Pharmacology, University of Vermont, Burlington, VT 05405 1; Institute of Cardiovascular Sciences, University of Manchester, Manchester M13 9PL, England, UK 2 Department of Pharmacology, Larner College of Medicine (O.F.H., N.R.K., A.J.S., D.C.H.-E., M.T.N.), University of Vermont, Burlington.; Vermont Center for Cardiovascular and Brain Health (O.F.H., M.T.N.), University of Vermont, Burlington.; Division of Cardiovascular Sciences, School of Medical Sciences (M.T.N.), University of Manchester, United Kingdom.; Geoffrey Jefferson Brain Research Centre, The Manchester Academic Health Science Centre, Northern Care Alliance NHS Group (M.T.N.), University of Manchester, United Kingdom. Department of Pharmacology, College of Medicine, The University of Vermont, Burlington, Vermont 05405; and Department of Pharmacology, College of Medicine, University of Vermont, Burlington, VT 05405;; Institute of Cardiovascular Sciences, University of Manchester, M13 9PL Manchester, United Kingdom Department of Pharmacology University of Vermont VT USA; Institute of Cardiovascular Sciences University of Manchester Manchester UK From the Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, University of Manchester, United Kingdom. Department of Pharmacology, Larner College of Medicine University of Vermont, Burlington, VT 05405, USA; Vermont Center for Cardiovascular and Brain Health, Larner College of Medicine University of Vermont, Burlington, VT 05405, USA; Division of Cardiovascular Sciences, University of Manchester, Manchester M13 9PL, UK Department of Pharmacology, College of Medicine, University of Vermont, Burlington, Vermont, USA; Institute of Cardiovascular Sciences, University of Manchester, Manchester, UK. Department of Pharmacology, College of Medicine, University of Vermont, Burlington, VT 05403, USA.; Institute of Cardiovascular Sciences, University of Manchester, Manchester M13 9NT, UK. Department of Pharmacology, University of Vermont, Burlington, United States; College of Medicine, University of Vermont, United States; Institute of Cardiovascular Sciences, University of Manchester, Manchester, United Kingdom Department of Pharmacology, University of Vermont, Burlington, VT 05405; Department of Pharmacology, College of Medicine, University of Vermont, Burlington, VT 05405, USA.; Institute of Cardiovascular Sciences, University of Manchester, Manchester M13 9NT, UK. Department of Pharmacology, University of Vermont College of Medicine, Burlington, Vermont;; Institute of Cardiovascular Sciences, University of Manchester, Manchester, United Kingdom Department of Surgery (Urology), University of Vermont Larner College of Medicine, Vermont Children’s Hospital, Burlington, Vermont; Institute of Cardiovascular Sciences, University of Manchester, Manchester, United Kingdom Department of Pharmacology, College of Medicine, University of Vermont, Burlington, VT 05405;; Institute of Cardiovascular Sciences, University of Manchester, Manchester M13 9NT, United Kingdom Department of Pharmacology University of Vermont Burlington VT USA; Institute of Cardiovascular Sciences University of Manchester Manchester UK Department of Pharmacology, University of Vermont, Burlington, Vermont Department of Pharmacology, University of Vermont College of Medicine Department of Pharmacology, University of Vermont, Burlington, VT; Institute of Cardiovascular Sciences, University of Manchester, UK Department of Pharmacology, Larner College of Medicine, University of Vermont, Burlington, VT 05405;; Division of Cardiovascular Sciences, University of Manchester, Manchester M13 9PL, United Kingdom Department of Pharmacology, Larner College of Medicine, University of Vermont, Burlington, VT, USA; Vermont Center for Cardiovascular and Brain Health, University of Vermont, Burlington, VT, USA; Division of Cardiovascular Sciences, University of Manchester, Manchester, UK Department of Pharmacology, College of Medicine, University of Vermont, Burlington, Vermont, USA; Department of Cardiovascular Medicine, Faculty of Medical and Human Sciences, University of Manchester, Manchester, UK Department of Pharmacology College of Medicine, University of Vermont Burlington Vermont; Institute of Cardiovascular Sciences, University of Manchester Manchester UK Department of Pharmacology, University of Vermont, Burlington, Vermont; Institute of Cardiovascular Sciences, University of Manchester, Manchester, United Kingdom Department of Pharmacology, University of Vermont, Burlington, VT, USA; Institute of Cardiovascular Sciences, University of Manchester, Manchester, UK Department of Pharmacology, College of Medicine, The University of Vermont, Colchester, Vermont 05446; and Department of Pharmacology, University of Vermont, Burlington, Vermont;; Institute of Cardiovascular Sciences, University of Manchester, Manchester, United Kingdom From the Department of Pharmacology, University of Vermont, Burlington. Department of Pharmacology College of Medicine University of Vermont Burlington Vermont USA; Institute of Cardiovascular Sciences University of Manchester Manchester UK Departments of Molecular Physiology and Biophysics and; Pharmacology, University of Vermont College of Medicine, Burlington, Vermont 05405 From the Department of Pharmacology (A.S.S., H.J.K., M.T.N.) and the Division of Cardiology (P.A.Z.), The University of Vermont, Burlington. From the Department of Pharmacology, University of Vermont, College of Medicine, Burlington, Vt. Present address for D.G.W. is Department of Physiology and Biophysics, University of Calgary, Alberta. Department of Pharmacology, College of Medicine, University of Vermont, Burlington, VT 05405 From the Department of Pharmacology (F.D., M.T.N., J.E.B.), University of Vermont, College of Medicine, Burlington, VT. Department of Pharmacology, the University of Vermont, Burlington, Vermont 05405 Department of Pharmacology, The University of Vermont, Burlington, VT 05405;; Division of Cardiovascular Sciences, The University of Manchester, Manchester M13 9PL, United Kingdom Department of Pharmacology, College of Medicine, The University of Vermont, Burlington, Vermont 05405 Department of Pharmacology, University of Vermont, Burlington, Vermont; and Department of Pharmacology, University of Vermont Larner College of Medicine, Burlington, Vermont; Division of Cardiovascular Sciences, University of Manchester, Manchester, United Kingdom Division of Cardiovascular Sciences, Faculty of Biology, Medicine, and Health, University of Manchester & Manchester University Teaching Hospitals NHS Foundation Trust, Manchester M13 9PL, United Kingdom; Department of Pharmacology, Larner College of Medicine, University of Vermont, Burlington, VT 05405 From the Department of Pharmacology, University of Vermont, Burlington, Vt. Department of Pharmacology, University of Vermont, Burlington, VT 05405-0068, USA; Vermont Center for Cardiovascular and Brain Health, Larner College of Medicine, University of Vermont, Burlington, VT 05405-0068, USA; Division of Cardiovascular Sciences, University of Manchester, Manchester, M13 9PL, UK. Electronic address: mark.nelson@uvm.ed. From the University of Vermont, Department of Pharmacology, Burlington, Vt. Department of Pharmacology, University of Vermont, Burlington, Vermont 05405; and *Department of Pharmacology, College of Medicine, University of Vermont, Burlington, VT 05405; Pharmacology, The University of Vermont, Burlington, Vermont 05405; Department of Pharmacology, University of Vermont, Burlington, VT 05405 Department of Pharmacology, University of Vermont Larner College of Medicine, Burlington, VT, USA; Division of Cardiovascular Sciences, University of Manchester, Manchester, UK Department of Pharmacology, University of Vermont, Burlington, VT 05405;; Institute of Cardiovascular Sciences, University of Manchester, Manchester M13 9PT, United Kingdom Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Center, Manchester M13 9NT, U.K.; Department of Pharmacology, University of Vermont, Burlington, VT 05405-0068, USA. |
Incoming Links
Total number of triples: 334.